➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Boehringer Ingelheim
Baxter
Dow
Express Scripts
Harvard Business School

Last Updated: July 6, 2020

DrugPatentWatch Database Preview

KINERET Drug Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Recent Clinical Trials for KINERET

Identify potential brand extensions & biosimilar entrants

SponsorPhase
M.D. Anderson Cancer CenterPhase 1/Phase 2
Fundacion Miguel ServetPhase 2/Phase 3
Centre Hospitalier Intercommunal de Toulon La Seyne sur MerPhase 2

See all KINERET clinical trials

Recent Litigation for KINERET

Identify key patents and potential future biosimilar entrants

District Court Litigation
Case NameDate
Celgene Corporation v. Aurobindo Pharma Limited2018-07-06
CELGENE CORPORATION v. EMCURE PHARMACEUTICALS LTD.2018-06-28
AMGEN INC v. SANDOZ INC.2018-06-26

See all KINERET litigation

PTAB Litigation
PetitionerDate
2015-06-02
2012-09-25

See all KINERET litigation

Pharmacology for KINERET

Company Disclosures: US Patents for KINERET

These patents were extracted from company disclosures
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Biovitrum Ab KINERET anakinra VIAL; SUBCUTANEOUS 103950 001 2001-11-14   Start Trial Synergen, Inc. (Boulder, CO) 2008-12-24 RX company
Biovitrum Ab KINERET anakinra VIAL; SUBCUTANEOUS 103950 001 2001-11-14   Start Trial Amgen Inc. (Thousand Oaks, CA) The Regents of the University of Colorado (Boulder, CO) 2020-07-29 RX company
Biovitrum Ab KINERET anakinra VIAL; SUBCUTANEOUS 103950 001 2001-11-14   Start Trial Amgen Inc. (Thousand Oaks, CA) The Regents of the University of Colorado (Boulder, CO) 2022-02-22 RX company
Biovitrum Ab KINERET anakinra VIAL; SUBCUTANEOUS 103950 002 2001-11-14   Start Trial Synergen, Inc. (Boulder, CO) 2008-12-24 RX company
Biovitrum Ab KINERET anakinra VIAL; SUBCUTANEOUS 103950 002 2001-11-14   Start Trial Amgen Inc. (Thousand Oaks, CA) The Regents of the University of Colorado (Boulder, CO) 2020-07-29 RX company
Biovitrum Ab KINERET anakinra VIAL; SUBCUTANEOUS 103950 002 2001-11-14   Start Trial Amgen Inc. (Thousand Oaks, CA) The Regents of the University of Colorado (Boulder, CO) 2022-02-22 RX company
Biovitrum Ab KINERET anakinra VIAL; SUBCUTANEOUS 103950 003 2001-11-14   Start Trial Synergen, Inc. (Boulder, CO) 2008-12-24 RX company
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Patent Text Search: US Patents for KINERET

These patents were identified by searching patent claims

Supplementary Protection Certificates for KINERET

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
SZ 44/2010 Austria   Start Trial PRODUCT NAME: DENOSUMAB
23/2002 Austria   Start Trial PRODUCT NAME: ANAKINRA; REGISTRATION NO/DATE: EU/1/02/203/001- EU/1/02/203/004 20020308
91757 Luxembourg   Start Trial PRODUCT NAME: DENOSUMAB ET SES DERIVES PHARMACEUTIQUEMENT ACCEPTABLES (PROLIA ); AUTHORISATION NUMBER AND DATE: EU/1/10/618/001-004 20100528
10299011 Germany   Start Trial PRODUCT NAME: KINERET(R) (WIRKSAMER BESTANDTEIL ANAKINRA); REGISTRATION NO/DATE: EU/1/02/203/001-004 20020308
300467 Netherlands   Start Trial PRODUCT NAME: DENOSUMAB; REGISTRATION NO/DATE: EU/1/10/618/001-004 20100528
CA 2020 00011 Denmark   Start Trial PRODUCT NAME: UPADACITINIB; REG. NO/DATE: EU/1/19/1404 20191218
10C0050 France   Start Trial PRODUCT NAME: DENOSUMAB; REGISTRATION NO/DATE: EU/1/10/618/001-004 20100528
>Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Boehringer Ingelheim
Merck
Dow
Medtronic
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.